Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2005
11/03/2005US20050244373 Composition for treatment of and method of monitoring hepatitis C virus using interferon-tau
11/03/2005US20050244372 Interleukin-3 (IL-3) multiple mutation polypeptides
11/03/2005US20050244371 Treating cancer using ultrapheresis; tissue necrosis factor receptor-2 (TNFR-2);
11/03/2005US20050244369 Dietary supplement
11/03/2005US20050244345 Method for preventing mineralization in the periodontal ligament (PDL)
11/03/2005US20050244341 Aerodynamically light particles for pulmonary drug delivery
11/03/2005US20050244334 Peptide consisting of Leu-Ala-Phe-Val-Leu-Arg-Lys-amide having at least one D amino acid
11/03/2005DE102004018405A1 Antibakterielle Amid-Makrozyklen II Antibacterial amide macrocycles II
11/03/2005DE102004017996A1 Stable anionic liposome depot system for prolonged release of protein or peptide drugs, e.g. insulin, comprising phosphatidyl choline, cholesterol, anionic lipid(s) and cationic polymer
11/03/2005CA2798552A1 Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
11/03/2005CA2564453A1 Peptide inhibitors of metalloproteinase activity
11/03/2005CA2563882A1 Corneal neuritogenesis promoter containing pacap and its derivative
11/03/2005CA2563877A1 Methods and kits for stabilising, protecting and solubilising proteins
11/03/2005CA2563874A1 Erythropoietin protein variants
11/03/2005CA2563754A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof
11/03/2005CA2563687A1 Use of a cgrp-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines
11/03/2005CA2562016A1 Nucleic acid based assays for identification of fc receptor polymorphisms
11/03/2005CA2559228A1 Bone delivery conjugates and method of using same to target proteins to bone
11/03/2005CA2557739A1 Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion
11/02/2005EP1591537A2 Hereditary hemochromatosis gene
11/02/2005EP1591530A2 A tumor necrosis factor related ligand
11/02/2005EP1591529A2 Human CLTA-8 and uses of CTLA-8-related proteins
11/02/2005EP1591528A2 Method and compositions for delivery and expression of interferon-alpha nucleic acids
11/02/2005EP1591526A2 Frazzled nucleotide sequences, expression products, compositions and uses
11/02/2005EP1591524A1 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus
11/02/2005EP1591453A1 Modified peptides yy and conjugates thereof
11/02/2005EP1591452A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591128A1 Thymosin beta 4 promotes wound repair
11/02/2005EP1591127A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE
11/02/2005EP1591116A1 Inhibitor for perioperative blood sugar elevation
11/02/2005EP1590666A1 Compositions and methods for enhancing apoptosis
11/02/2005EP1590613A2 Lyophilization method and apparatus for producing particles
11/02/2005EP1590480A2 Novel proteins and nucleic acids encoding same
11/02/2005EP1590468A2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/02/2005EP1590462A2 Mucin-like polypeptides
11/02/2005EP1590460A1 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements
11/02/2005EP1590457A2 Oligonucleotides directed against a survivin gene and use thereof
11/02/2005EP1590453A2 Custom-made meganuclease and use thereof
11/02/2005EP1590442A2 Macrocyclic hepatitis c serine protease inhibitors
11/02/2005EP1590441A2 Methods and compositions for treating hematological disorders using 9118, 990, 17662, 81982, 630, 21472, 17692, 19290, 21620, 21689, 28899, 53659, 64549, 9465, 23544, 7366, 27417, 57259, 21844, 943, 2061, 5891, 9137, 13908, 14310, 17600, 25584, 27824, 28469, 38947, 53003, 965, 56639, 9661, 16052, 15
11/02/2005EP1590438A2 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera
11/02/2005EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/02/2005EP1590430A2 SiRNA MEDIATED POST-TRANSRIPTIONAL GENE SILENCING OF GENES INVOLVED IN ALOPECIA
11/02/2005EP1590368A1 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
11/02/2005EP1590366A1 Peptidic sulfonamides
11/02/2005EP1590363A2 Bh3 peptides and method of use thereof
11/02/2005EP1590001A2 Method for in vivo regulation of cardiac muscle contractility
11/02/2005EP1589998A2 Uses of mammalian cytokine; related reagents
11/02/2005EP1589993A2 Combination therapy for treating protein deficiency disorders
11/02/2005EP1589992A2 Method for treating elevated intraocular pressure, including glaucoma
11/02/2005EP1589991A1 Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
11/02/2005EP1589990A2 Method for treating cancer in humans
11/02/2005EP1589989A2 Osteogenic composition
11/02/2005EP1589988A2 Modulation of activity of neurotrophins
11/02/2005EP1589987A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
11/02/2005EP1589986A2 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
11/02/2005EP1589985A2 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620
11/02/2005EP1589984A2 Topical composition and methods for treatment of aged or environmentally damaged skin
11/02/2005EP1589981A2 Interferon antagonists useful for the treatment of interferon related diseases
11/02/2005EP1589980A2 Methods of diagnosis and treatment of interstitial lung disease
11/02/2005EP1589949A1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
11/02/2005EP1589943A2 Methods of treating lung diseases
11/02/2005EP1589933A2 Compositions and methods for the diagnosis and treatment of tumor
11/02/2005EP1589931A2 RNAi TARGETING OF VIRUSES
11/02/2005EP1589811A2 Non-touch zona pellucida microdrilling of a single-cell embryo with a 1.48 um diode laser beam for introduction of retrovirus
11/02/2005EP1368056B1 Recombinant gelatin-like proteins for use as plasma expanders
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1254164B1 Selective n-acylation of a82846 glycopeptide analogs
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1200123B1 Diagnosis and treatment of neuroectodermal tumors
11/02/2005EP1196128B1 Preserving a hemoglobin blood substitute with a transparent overwrap
11/02/2005EP1183355B1 T-bet compositions and methods of use thereof
11/02/2005EP1168923B1 Dna vaccination for treatment of autoimmune disease
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1067944B1 Combined preparation comprising monocyte derived cells and chemotherapy drugs for the treatment of neoplasic diseases or of infectious diseases
11/02/2005EP1061873B1 Use of glyceraldehyde as corneal hardening agents
11/02/2005EP1011767B1 Device for administering insulin in controlled dosages by controlling total inhaled volume
11/02/2005EP1005488B1 Receptor that binds trail
11/02/2005EP1002092B1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/02/2005EP0994706B1 Compositions for administering taxanes orally to human patients and their use
11/02/2005EP0979097B1 Hgf for treating acute renal failure
11/02/2005EP0973540B1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
11/02/2005EP0951537B1 Recombinant collagen produced by plants, methods for obtaining them and uses
11/02/2005EP0920332B1 Combination of the proteolytic enzymes trypsin, bromelain and papain for treating glomerulonephritis
11/02/2005EP0793675B1 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission
11/02/2005EP0601135B1 Osteogenic proteins in the treatment of metabolic bone diseases
11/02/2005CN1692124A P53 binding T cell receptor molecules and uses thereof
11/02/2005CN1692121A A full-length polynucleotide sequence coding chicken type II collagen and the use of it
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1691961A Cysteine protease inhibitor
11/02/2005CN1691960A Inhibitors for continuous activation of calcineurin
11/02/2005CN1691959A Interleukin 6 production inhibitor
11/02/2005CN1691958A Enos mutants useful for gene therapy
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691956A Asialo-interferons and the treatment of liver cancer
11/02/2005CN1691951A Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds
11/02/2005CN1690203A Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2005CN1689646A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
1 ... 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 ... 3163